Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

In this week's episode, Blood editor Dr. James Griffin interviews Drs. George Goshua, Gerd Blobel, and Paul Kaminski on their latest articles published in Blood . Dr. Goshua elaborates on the background and then insights from " Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis ". This analysis provides valuable guidance for clinicians,…